On July 14, Yuanhua Intelligence, a developer of orthopedic surgical robots, held a strategic financing signing ceremony, announcing that it has received tens of millions of yuan in angel round from Shenzhen Capital Group.
The proceeds will mainly be used for the clinical trials of the company's total knee replacement surgical robot, as well as the research and development of the company's other subsequent products.
Yuanhua Intelligence is a developer of medical surgery robotics.
The company is mainly engaged in the research and development of medical surgery robotics such as the orthopedic surgery assistant robot that are used in knee and hip replacement, trauma nail placement, and spinal lamina resection, assisting surgeons in operations.
"Yuanhua Intelligence’s products are highly positioned and have broad market prospects,” said Zhang Jian, vice president of Shenzhen Capital Group. “The team is well structured, with outstanding talents in R&D, production and marketing, we are confident to accompany Yuanhua to become a great company.”